Financhill
Back

Calidi Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
41

CLDI
Calidi Biotherapeutics

Last Price:
1.20
Seasonality Move:
-29.17%
Sell
49

NBY
NovaBay Pharmaceuticals

Last Price:
0.70
Seasonality Move:
-22.66%
Sell
41
Calidi Biotherapeutics (CLDI) is a Sell

Is Calidi Biotherapeutics a Buy, Sell or Hold?

  • The current Calidi Biotherapeutics [CLDI] share price is $1.21. The Score for CLDI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CLDI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLDI Stock Price Chart

What is Calidi Biotherapeutics's stock price today?

  • The Calidi Biotherapeutics share price today is $1.21
    The current trend is relatively stagnant and CLDI is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

CLDI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 48.03 Sell
Chaikin Money Flow: 93304 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.12 - 1.18) Buy
Bollinger Bands (100): (1.28 - 2.18) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 57.14 Buy
Chaikin Money Flow: 63291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.44 - 0.64) Buy
Bollinger Bands (100): (0.44 - 3.24) Sell

CLDI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.15 Buy
20-day SMA: 1.15 Buy
50-day SMA: 1.38 Sell
200-day SMA: 5.07 Sell
8-day EMA: 1.17 Buy
20-day EMA: 1.19 Buy
50-day EMA: 1.42 Sell
200-day EMA: 11.49 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Buy
20-day SMA: 0.55 Buy
50-day SMA: 0.69 Buy
200-day SMA: 3.51 Sell
8-day EMA: 0.67 Buy
20-day EMA: 0.61 Buy
50-day EMA: 0.9 Sell
200-day EMA: 7.9 Sell

Calidi Biotherapeutics Earnings Growth & CLDI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Calidi Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):